March 2026 Options Now Available For Ascendis Pharma (ASND)

Ascendis Pharma (ASND) options present income-oriented opportunities: a March 2026 $210 put is bid at $20, which if sold-to-open would obligate purchase at $210 and net a $190 effective cost basis (before commissions), is about 2% OTM with a 56% probability of expiring worthless and would yield 9.52% on the cash commitment (35.49% annualized, per Stock Options Channel). On the call side, selling a March 2026 $220 covered call (bid $16.50) against shares bought at $213.19 would cap sale at $220, is ~3% OTM with a 51% chance to expire worthless, and would add 7.74% (28.84% annualized) in premium, delivering a 10.93% total return if called away. Implied volatility on both contracts is ~53% versus a trailing 12‑month realized volatility of ~41%, indicating option premium is elevated; the trades offer attractive annualized yields but carry the usual execution risk of assignment or capped upside.

Analysis

The put-side trade offers a March 2026 $210 put bid at $20.00; selling-to-open obligates purchase at $210 but nets an effective cost basis of $190.00 versus the current ASND price of $213.19, the strike sits ~2% out-of-the-money and Stock Options Channel estimates a 56% probability the contract will expire worthless, which they translate to a 9.52% return on the cash commitment (35.49% annualized).

On the call side, the March 2026 $220 covered call is bid at $16.50; buying shares at $213.19 and selling that call would cap proceeds at $220 and, including premium, produces a 10.93% total return if assigned, with the option ~3% out-of-the-money and a 51% chance to expire worthless providing a 7.74% premium boost (28.84% annualized).

Implied volatility on both contracts is ~53% versus a trailing 12-month realized volatility of ~41%, indicating elevated option premia; primary risks are assignment on either strategy and forgone upside for the covered-call seller. Stock Options Channel will track and publish odds and option trading history, so changes in implied volatility or stock price should be monitored closely before and after trade entry.

Key Decisions for Investors

• Consider selling the $210 March 2026 put if you are willing to own ASND at a $190 effective cost basis and accept the stated 56% chance of expiry worthless (and the complementary assignment risk),
• If you already own or plan to buy ASND at $213.19, consider selling the $220 March 2026 covered call to capture a 7.74% premium (10.93% if called), while acknowledging capped upside and the 51% chance of expiry worthless,
• Monitor implied volatility (~53%) versus realized volatility (~41%) and the Stock Options Channel odds charts; if implied vol compresses or ASND moves materially, reassess premiums and hedging needs before rolling or entering positions